Navigation Links
Alaris system

ProductsAlaris system
Company ALARIS Medical Systems, Inc.
Item Alaris system
Features Anesthesia/OR
  • Key-press audio "clicks" turned off
  • Additional OR drugs and OR-only limits
  • Anesthesia Mode becomes disabled when the device is disconnected from AC power and reverts back to the original profile for additional safety
  • Indefinite channel pause with no call-back
  • All limits for the safety software are set to "soft"


  • Exceptional rate accuracy (+/- 2%)
  • Flow rates from 0.01 mL/hr to 999 mL/hr
  • Compatible with a wide range of syringes and brands
  • Unique and unmatched pressure-monitoring capabilities
  • Intuitive syringe-loading process

    Pain management

  • Built-in safety check for every PCA delivery, including pre-filled and pharmacy filled drugs
  • Customizable drug library for all care areas
  • Ability to combine PCA, large-volume pump and patient monitoring into one compact platform with a single user interface
  • Combined PCA-dosing history and SpO2 or EtCO2* values on a single platform
  • Industry leading Nellcor, Masimo and Oridion monitoring technologies available
  • First-of-its-kind CQI results for pain management process improvement

    Med surg/general ward

  • Modular platform standardizes devices throughout the hospital
  • Earlier identification of programming errors, before a medication error can occur
  • Smart infusion technology for a care area often overlooked when it comes to cutting-edge technology


  • Ability to schedule multiple-dose therapies based on the optimum times for each particular patient
  • Configurable with a variety of disposable set options including DEHP-free sets, secondary sets and manifold sets
  • Easy to ambulate

    Critical care

  • Ability to add or subtract modules as needed
  • Single interface for simplified training
  • Vertical alignment of channel lines for easy view
  • Single battery and power cord for up to 4 channels
  • Unmatched flexibility in customizing drug limits, with up to 1,000 drug and care applications
  • Description The Alaris System integrates drug infusion with patient monitoring and clinical best practice guidelines into a single, modular platform. With multiple configuration options, you can add or remove modules as you need them, keeping the number of devices at the bedside to a minimum while managing the unique needs of each patient.

    While the Alaris System offers maximum flexibility, it also incorporates a common user interface and alert system across multiple bedside devices, enabling you to standardize your infusion and monitoring systems across all areas of the hospital. We offer you a systems approach for all your care areas, rather than simply applying a new technology to "pockets of your facility. The modularity of this medication safety system also assists in effective asset utilization throughout the hospital.

    The Alaris System works with you to standardize best practices for medication safety from individual care areas to each specific patient.

    Info ALARIS Medical Systems, Inc.
    Customer Service: 800-854-7128
    Web site:

    Related medicine products :

    1. SuperVu 2.5x Galilean system
    2. SuperVu 2.0x Galilean system
    3. SuperVu 3.0x Galilean system
    4. Catalyst system
    5. Headband headlight system
    6. Sweatband headlight system
    7. Headband headlight system (10-75 mm variable spot)
    8. Headband headlight system (100 mm fixed spot)
    9. IMx system
    10. TDx system
    11. Long system Ventriculoscope
    ... the active lifestyle, the Chesterfield ... for men, women and children., ... wide variety of design options, ... young, relaxed attitude, and children ...
    ... doctors, tests for elevated thyroid stimulating hormone ... the first clinical indicator of hypothyroidism. , ... to use, cost effective and accurate. ... programs and health promotion. , ThyroChek is CLIA ...
    VertiGraft allografts for spine surgery deliver the strength adn performance you demand in your procedures and they are backed by quality and safety standards that are unmatched in the industry....
    Medicine Products:
    (Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
    (Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
    (Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from reveals ...
    (Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
    (Date:6/24/2016)... Fla. (PRWEB) , ... June 24, 2016 , ... Global ... Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition ... Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this year’s ...
    Breaking Medicine News(10 mins):
    (Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
    (Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
    (Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
    Breaking Medicine Technology: